drugset / Trial / NCT06670534

A Dose-finding Study of JMKX003142 in Treatment of Renal Edema

NCT06670534

Phase 2 Recruiting 216 enrolled Jemincare
RandomizedParallel-groupOpen-labelTreatment

Summary

To Evaluate the Safety, Efficacy, and Pharmacokinetic Characteristics of JMKX003142 Administered Randomly, Open-label, Active-controlled Study in Chinese Renal Edema Patients.

Timeline

Start
2025-01-07
Primary completion
2026-07-15
Completion
2026-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject JMKX003142 Unknown Oral
Comparator Torasemide Unknown 20 mg Oral

Indications

No indication recorded.